ABSTRACT
Herein we report studies on a bimesogen that exhibits a chiral twist bend nematic phase when doped with small weight percentages of a chiral material and a partial phase diagram constructed. At low concentrations a wide temperature range blue phase is observed, whereas at higher concentrations an additional 'nematic-like' mesophase was discovered at a lower temperature than the twist-bend nematic phase. In addition to an apparent isotropic-"isotropic" transition, the doped materials also exhibited a weakly birefringent phase upon annealing in the isotropic liquid phase, implying pretransitional behaviour in the same vein as that seen for TGB phases. When confined in a planar aligned cell, the NTB phase exhibited two domains that alternated between light and dark with rotation of the sample stage, as well as the application of an external electric field. Upon the addition of a chiral dopant one of these domains was eliminated, leading to their assignment as twist domains of opposite handedness.
ABSTRACT
The nematic twist-bend phase (NTB) was, until recently, only observed for polar mesogenic dimers, trimers or bent-core compounds. In this article, we report a comprehensive study on novel apolar materials that also exhibit NTB phases. The NTB phase was observed for materials containing phenyl, cyclohexyl or bicyclooctyl rings in their rigid-core units. However, for materials with long (>C7) terminal chains or mesogenic core units comprising three ring units, the NTB phase was not observed and instead the materials exhibited smectic phases. One compound was found to exhibit a transition from the NTB phase to an anticlinic smectic C phase; this is the first example of this polymorphism. Incorporation of lateral substitution with respect to the central core unit led to reductions in transition temperatures; however, the NTB phase was still found to occur. Conversely, utilising branched terminal groups rendered the materials non-mesogenic. Overall, it appears that it is the gross molecular topology that drives the incidence of the NTB phase rather than simple dipolar considerations. Furthermore, dimers lacking any polar groups, which were prepared to test this hypothesis, were found to be non mesogenic, indicating that at the extremes of polarity these effects can dominate over topology.
ABSTRACT
BACKGROUND: Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle, manifested as a life-threatening hypermetabolic crisis after exposure to anesthetics. Type I ryanodine receptor 1 is the primary gene responsible for susceptibility to MH as well as central core disease, a congenital myopathy that predisposes susceptibility to MH. More than 40 mutations in the RyR1 gene cluster in three coding regions: the N-terminus, central, and C-terminus regions. However, the frequency of mutations in each region has not been studied in the North American MH-susceptible population. METHODS: The authors tested 124 unrelated patients with MH susceptibility for the presence of mutations in the N-terminus (exons 2, 6, 9, 11, 12, and 17), central (exons 39, 40, 44, 45, and 46), and C-terminus (exons 95, 100, 101, and 102) regions. RESULTS: Fourteen mutations have been identified in 29 of 124 MH-susceptible patients (23%). Approximately 70% of the mutations, which include a novel mutation, Ala 2437Val, were in the central region. In 8 patients (28%), mutations were identified in the N-terminus region. Screening the C-terminus region yielded a novel mutation, Leu4824Pro, in a single patient with a diagnosis of central core disease. CONCLUSIONS: The detection rate for mutations is only 23% by screening mutations (or exons) listed in the 2002 North American consensus panel. The implications from this study suggest that testing the central region first is currently the most effective screening strategy for the North American population. Screening more exons in the three hot spots may be needed to find an accurate frequency of mutations in the RyR1 gene.
